Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award
- PMID: 32336227
- PMCID: PMC7225070
- DOI: 10.1161/HYPERTENSIONAHA.120.13896
Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award
Abstract
For over 100 years, essential hypertension has been researched from different perspectives ranging from genetics, physiology, and immunology to more recent ones encompassing microbiology (microbiota) as a previously underappreciated field of study contributing to the cause of hypertension. Each field of study in isolation has uniquely contributed to a variety of underlying mechanisms of blood pressure regulation. Even so, clinical management of essential hypertension has remained somewhat static. We, therefore, asked if there are any converging lines of evidence from these individual fields that could be amenable for a better clinical prognosis. Accordingly, here we present converging evidence which support the view that metabolic dysfunction underlies essential hypertension.
Keywords: blood pressure; cardiovascular disease; hypertension; hyperuricemia; mitochondria.
Figures
References
-
- Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the united states during the 20th century. JAMA. 1999;281:61–66. - PubMed
-
- Centers for Disease C, Prevention. Control of infectious diseases. MMWR Morb Mortal Wkly Rep. 1999;48:621–629. - PubMed
-
- Chatterjee A, Modarai M, Naylor NR, Boyd SE, Atun R, Barlow J, Holmes AH, Johnson A, Robotham JV. Quantifying drivers of antibiotic resistance in humans: A systematic review. Lancet Infect Dis. 2018;18:e368–e378. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
